The ‘Medical Device CROs Market (2nd Edition), 2020-2030
KeyInclusions
§ A detailed review of the overall landscape of medicaldevice CROs, along with information on year of establishment, company size,location of headquarters, type of service offered by [A] clinical serviceproviders (biostatistics, consulting,clinical operations, post marketing surveillance / studies, quality assurance,regulatory affairs management, reimbursement and training), [B] preclinicalservice providers (consulting, biocompatibility testing, materialscharacterization and analytical testing, preclinical trials support, sterilitytesting and microbiology testing, and training) and [C] stand-alone serviceproviders (consulting, training, quality assurance, clinical operations, andregulatory affairs management).
§ An elaborate discussion on the various guidelinesestablished by major regulatory bodies for medical device approval across NorthAmerica (the US, Canada and Mexico), Europe (France, Germany, Italy, Spain, theUK and rest of Europe), and Asia-Pacific and rest of the world (Australia,Brazil, China, India, Israel, Japan, New Zealand, Singapore, South Africa,South Korea, Taiwan, and Thailand). The report also features an insightfulmulti-dimensional, heat map analysis, featuring a comparison of thecontemporary regulatory and reimbursement scenarios in key geographies acrossthe globe.
§ Elaborate profiles of key players that specialize inoffering services for both clinical and preclinical stage development ofmedical devices. Each profile features an overview of the company, along withinformation on year of establishment, number of employees, location ofheadquarters, presence across key geographies, target therapeutic areas,financial details (if available), medical device focused serviceportfolio, and an informed future outlook.
§ An analysis highlighting the key performance indicatorsused by sponsor companies to evaluate service providers engaged in this domain,based on information gathered via secondary research (for top-ten medicaldevice players) and primary research.
§ A competitive benchmarking, highlighting the key focusareas of small, mid-sized and large companies, comparing their existingcapabilities within and beyond their respective peer groups, and providing ameans for stakeholders to identify ways to gain a competitive advantage in theindustry.
§ A detailed brand positioning analysis of leading industryplayers (shortlisted on the basis of strength of service portfolio),highlighting the current perceptions regarding their proprietary brands acrossdifferent device classes.
§ A detailed geographical clinical trial analysis of ongoingand planned studies related to medical devices, along with information onnumber of registered trials, location of trial site, current status of trials,current phase of trial, type of sponsor, target therapeutic area(s) and numberof patients enrolled.
§ A detailed analysis of the mergers and acquisitions thathave taken place in this domain during the period 2015-2020, highlightinggeographical activity. The analysis also features an ownership change matrix,providing a summary of the involvement of private and public sector entities inthis domain.
§ A survey analysis featuring inputs solicited from variousexperts who are directly / indirectly involved in providing contract researchservices to medical device developers.
§ A discussion on affiliated trends, key drivers andchallenges, under a SWOT framework, which are likely to impact the industry’sevolution, including a Harvey ball analysis, highlighting the relative effectof each SWOT parameter on the overall medical device CRO industry.
§ An elaborate discussion on the future opportunities /trends for the medical device outsourcing market that are likely to influencethe growth of this domain over the coming years.
§ Informed estimates of the existing market size and thefuture opportunity for medical device CROs, over the next decade.
The report alsofeatures the likely distribution of the current and forecasted opportunityacross important market segments, mentioned below:
§ Phase of Development
§ Clinical
§ Preclinical
§ Types of PreclinicalServices Offered
§ Biocompatibilitytesting
§ Sterility andmicrobiology testing
§ Materialcharacterization and analytical services
§ Others
§ Types of ClinicalServices Offered
§ Clinical trialmanagement
§ Data management
§ Regulatory affairsmanagement
§ Consulting
§ Others
§ Device Class
§ Class I medical devices
§ Class II medicaldevices
§ Class III medicaldevices
§ Target TherapeuticArea
§ CNS disorders
§ Cardiovasculardisorders
§ Oncological disorders
§ Bone disorders
§ Respiratory disorders
§ Pain managementdisorders
§ Ophthalmic disorders
§ Psychologicaldisorders
§ Metabolic disorders
§ Others
§ Key GeographicalRegions
§ North America
§ Europe
§ Asia-Pacific
§ Rest of the World
Thereport includes detailed transcripts of discussions held with the followingexperts:
§ Lajos Sarosi (ChiefExecutive Officer and Co-founder, HungaroTrial)
§ Christopher Rupp(Vice President of Global Marketing and Commercial Operations, NAMSA)
§ Christian Wolflehner (GeneralManager, CW Research & Management)
§ Troy Mccall (ChiefOperating Officer, CROMSOURCE)
§ Nazish Urooj (Seniormanager, Medical & Clinical Operations, Metrics Research)
§ C. Omprakash (TechnicalDirector and Partner, Vyomus Consulting)
§ Tania Persson (Directorof Business Development, A+ Science)
§ Alexa Foltin-Mertgen(Business Development Manager, AtoZ-CRO)
To request sample pages, please visit this - https://www.rootsanalysis.com/reports/226/request-sample.html
Key Questions Answered
§ Whoare the leading players that offer contract research services for medicaldevices? Which companies have relatively stronger brand positioning?
§ Howdoes the market landscape vary across different regions of the world?
§ Whatare the key value drivers of the merger and acquisition activity in the medicaldevice CRO industry?
§ Whatare the key differences in regulatory requirements for medical device approval,across various geographies?
§ Whatare the different payment systems and reimbursement strategies being adopted formedical devices?
§ Whatare the key performance indicators used by sponsors to evaluate potentialservice providers?
§ Howis the current and future market opportunity likely to be distributed acrosskey market segments?
§ What are the upcomingopportunities / trends of medical device contract services market that arelikely to impact the future evolution of this domain over the coming years?
Youmay also be interested in the following titles:
1. Contract RegulatoryAffairs Management Market for Medical Devices, 2019-2030
2. Medical Device LabelsManufacturing Market, 2019 - 2030
3. Medical Device ContractManufacturing Market, 2019-2030
Contact Us
Gaurav Chaudhary
+1 (415) 800 3415
